Variant report

Variant	nsv539877
Chromosome Location	chr9:222282-654518
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:4292)
CpG islands
(count:854)
Chromatin interactive
region (count:218)
LncRNA
region (count:74)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:4292 , 50 per page) page: 1 2 3 4 5 6 7 ... 86

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:238911-239096	K562	blood:	n/a	n/a
2	ARID3A	chr9:267916-268404	K562	blood:	n/a	n/a
3	ARID3A	chr9:489187-489524	HepG2	liver:	n/a	n/a
4	ARID3A	chr9:272758-273406	K562	blood:	n/a	chr9:273064-273079
5	ARID3A	chr9:250210-251866	K562	blood:	n/a	n/a
6	ARID3A	chr9:613790-614724	HepG2	liver:	n/a	n/a
7	ARID3A	chr9:371491-371553	K562	blood:	n/a	n/a
8	ARID3A	chr9:237608-238477	K562	blood:	n/a	n/a
9	ARID3A	chr9:592251-592433	HepG2	liver:	n/a	n/a
10	ARID3A	chr9:463883-464115	HepG2	liver:	n/a	n/a
11	ARID3A	chr9:260270-260544	K562	blood:	n/a	n/a
12	ARID3A	chr9:229136-229466	K562	blood:	n/a	n/a
13	ARID3A	chr9:336046-336405	HepG2	liver:	n/a	n/a
14	ARID3A	chr9:504390-504746	K562	blood:	n/a	n/a
15	ARID3A	chr9:495829-496174	HepG2	liver:	n/a	n/a
16	ARID3A	chr9:272095-272522	K562	blood:	n/a	n/a
17	ATF1	chr9:491995-492195	K562	blood:	n/a	n/a
18	ATF1	chr9:428430-428702	K562	blood:	n/a	n/a
19	ATF1	chr9:222266-222777	K562	blood:	n/a	n/a
20	ATF1	chr9:249153-249485	K562	blood:	n/a	n/a
21	ATF1	chr9:270753-271026	K562	blood:	n/a	n/a
22	ATF1	chr9:272781-273161	K562	blood:	n/a	n/a
23	ATF1	chr9:272150-272512	K562	blood:	n/a	n/a
24	ATF1	chr9:312958-313372	K562	blood:	n/a	n/a
25	ATF2	chr9:272677-273240	GM12878	blood:	n/a	n/a
26	ATF2	chr9:272650-273286	GM12878	blood:	n/a	n/a
27	ATF2	chr9:297286-297859	GM12878	blood:	n/a	n/a
28	ATF3	chr9:557723-558324	A549	lung:	n/a	n/a
29	ATF3	chr9:326568-327022	H1-hESC	embryonic stem cell:	n/a	n/a
30	ATF3	chr9:272081-272576	K562	blood:	n/a	n/a
31	BACH1	chr9:557912-558114	H1-hESC	embryonic stem cell:	n/a	n/a
32	BACH1	chr9:503882-504954	H1-hESC	embryonic stem cell:	n/a	n/a
33	BACH1	chr9:505331-505595	H1-hESC	embryonic stem cell:	n/a	n/a
34	BACH1	chr9:652937-653241	H1-hESC	embryonic stem cell:	n/a	n/a
35	BACH1	chr9:561382-561724	H1-hESC	embryonic stem cell:	n/a	n/a
36	BACH1	chr9:470546-470746	H1-hESC	embryonic stem cell:	n/a	n/a
37	BACH1	chr9:450112-450344	H1-hESC	embryonic stem cell:	n/a	n/a
38	BACH1	chr9:503516-503574	H1-hESC	embryonic stem cell:	n/a	n/a
39	BATF	chr9:297420-297885	GM12878	blood:	n/a	chr9:297684-297695 chr9:297685-297695
40	BATF	chr9:297422-297902	GM12878	blood:	n/a	chr9:297684-297695 chr9:297685-297695
41	BATF	chr9:278668-278987	GM12878	blood:	n/a	n/a
42	BCL11A	chr9:331212-331567	H1-hESC	embryonic stem cell:	n/a	n/a
43	BCL3	chr9:557812-558394	A549	lung:	n/a	n/a
44	BCL3	chr9:503842-504488	A549	lung:	n/a	chr9:504175-504184 chr9:504327-504340 chr9:504456-504469
45	BCL3	chr9:561341-561682	GM12878	blood:	n/a	n/a
46	BCL3	chr9:489067-489648	A549	lung:	n/a	n/a
47	BCL3	chr9:469817-470210	A549	lung:	n/a	chr9:470121-470130
48	BCL3	chr9:561269-561869	A549	lung:	n/a	n/a
49	BCL3	chr9:470157-470838	A549	lung:	n/a	n/a
50	BCL3	chr9:463755-464226	A549	lung:	n/a	n/a

(count:854 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:470109-470159	GM12892	blood:	n/a
2	chr9:505721-505771	Hepatocyte	liver:	n/a
3	chr9:472966-473016	GM19239	blood:	n/a
4	chr9:469777-469827	HAEpiC	amniotic membrane:	n/a
5	chr9:505235-505285	AoSMC	blood vessel:	n/a
6	chr9:273072-273122	AG09309	skin:	n/a
7	chr9:470323-470373	CMK	blood:	n/a
8	chr9:505571-505621	Caco-2	colon:	n/a
9	chr9:505721-505771	IMR90	lung:	fetal
10	chr9:504774-504824	HCM	heart:	n/a
11	chr9:574312-574362	HIPEpiC	eye:	n/a
12	chr9:505235-505285	HCM	heart:	n/a
13	chr9:469777-469827	HepG2	liver:	n/a
14	chr9:472966-473016	CMK	blood:	n/a
15	chr9:472966-473016	K562	blood:	n/a
16	chr9:507411-507461	HEK293	kidney:	embryo
17	chr9:504774-504824	NB4	blood:	n/a
18	chr9:426894-426944	NB4	blood:	n/a
19	chr9:503937-503987	ovcar-3	ovarian:	n/a
20	chr9:469777-469827	GM12892	blood:	n/a
21	chr9:505235-505285	AG04450	lung:	fetal
22	chr9:426894-426944	HEEpiC	esophagus:	n/a
23	chr9:470323-470373	AG04450	lung:	fetal
24	chr9:503937-503987	HMEC	breast:	n/a
25	chr9:273072-273122	LNCaP	prostate:	n/a
26	chr9:505721-505771	HCPEpiC	choroid plexus:	n/a
27	chr9:504774-504824	HepG2	liver:	n/a
28	chr9:504774-504824	GM06990	blood:	n/a
29	chr9:505571-505621	ECC-1	luminal epithelium:	n/a
30	chr9:273072-273122	AoSMC	blood vessel:	n/a
31	chr9:505721-505771	AG04449	skin:	fetal
32	chr9:470323-470373	HCM	heart:	n/a
33	chr9:470109-470159	MCF10A-Er-Src	breast:	n/a
34	chr9:504774-504824	NT2-D1	testis:	n/a
35	chr9:471920-471970	CMK	blood:	n/a
36	chr9:504774-504824	HCPEpiC	choroid plexus:	n/a
37	chr9:504774-504824	NH-A	brain:	n/a
38	chr9:507411-507461	T-47D	breast:	n/a
39	chr9:469777-469827	NHBE	bronchial:	n/a
40	chr9:470323-470373	U87	brain:	n/a
41	chr9:470109-470159	AoSMC	blood vessel:	n/a
42	chr9:574312-574362	HMEC	breast:	n/a
43	chr9:507411-507461	CMK	blood:	n/a
44	chr9:574312-574362	LNCaP	prostate:	n/a
45	chr9:426894-426944	Hela-S3	cervix:	n/a
46	chr9:503937-503987	AoSMC	blood vessel:	n/a
47	chr9:503937-503987	IMR90	lung:	fetal
48	chr9:503937-503987	NHBE	bronchial:	n/a
49	chr9:273072-273122	HRPEpiC	eye:	n/a
50	chr9:471920-471970	GM19239	blood:	n/a

(count:218 , 50 per page) page: 1 2 3 4 5

No.	Distal block	Cell Line	Cell type
1	chr9:316274..318543-chr9:331270..334145,2	MCF-7	breast:
2	chr9:277861..283096-chr9:291676..296273,5	K562	blood:
3	chr12:21809676..21810203-chr9:455132..455632,2	NB4	blood:
4	chr9:253544..257279-chr9:268731..273892,6	K562	blood:
5	chr9:469030..473266-chr9:476113..479118,4	MCF-7	breast:
6	chr9:264854..268401-chr9:271602..276392,5	K562	blood:
7	chr9:613650..614569-chr9:806256..807252,7	MCF-7	breast:
8	chr9:223210..226112-chr9:277917..282090,3	K562	blood:
9	chr17:56717189..56717712-chr9:242303..242942,2	MCF-7	breast:
10	chr9:634722..638024-chr9:640128..643682,5	MCF-7	breast:
11	chr9:212468..215901-chr9:260350..263868,4	K562	blood:
12	chr9:265556..268525-chr9:268878..270498,2	K562	blood:
13	chr9:535330..537087-chr9:549296..551126,2	K562	blood:
14	chr9:468830..470676-chr9:503247..506779,4	MCF-7	breast:
15	chr9:244363..245872-chr9:248878..250809,2	K562	blood:
16	chr9:581871..582698-chr9:763741..764739,5	MCF-7	breast:
17	chr9:495605..498122-chr9:502386..505122,3	MCF-7	breast:
18	chr9:213587..215367-chr9:247326..250011,2	MCF-7	breast:
19	chr9:268983..271562-chr9:284279..286719,2	MCF-7	breast:
20	chr9:387700..389795-chr9:395557..397565,2	MCF-7	breast:
21	chr9:212545..218648-chr9:270340..281940,20	K562	blood:
22	chr9:284961..287002-chr9:306876..309185,2	K562	blood:
23	chr9:347478..348338-chr9:806313..807172,2	MCF-7	breast:
24	chr10:74033442..74034170-chr9:469881..470831,2	NB4	blood:
25	chr9:438728..443718-chr9:444221..448963,4	K562	blood:
26	chr9:243324..246093-chr9:246428..250809,6	K562	blood:
27	chr9:226722..229215-chr9:247840..250679,2	K562	blood:
28	chr9:235818..237375-chr9:247234..248835,2	K562	blood:
29	chr9:224695..226653-chr9:227779..229816,2	K562	blood:
30	chr9:581649..582215-chr9:998516..999103,2	MCF-7	breast:
31	chr9:487771..490019-chr9:514331..516293,2	MCF-7	breast:
32	chr9:303334..306488-chr9:313112..315414,3	MCF-7	breast:
33	chr9:243324..246093-chr9:246428..250809,6	K562	blood:
34	chr9:438728..443718-chr9:444221..448963,4	K562	blood:
35	chr9:316274..318543-chr9:331270..334145,2	MCF-7	breast:
36	chr9:555602..557901-chr9:561314..563396,2	K562	blood:
37	chr9:582031..585321-chr9:586707..590039,3	K562	blood:
38	chr9:247322..249745-chr9:277912..279940,2	K562	blood:
39	chr9:213868..216890-chr9:248711..251891,4	K562	blood:
40	chr9:396391..399763-chr9:403196..405645,3	K562	blood:
41	chr9:468830..470676-chr9:503247..506779,4	MCF-7	breast:
42	chr9:223853..225771-chr9:261619..263535,2	K562	blood:
43	chr9:212741..215221-chr9:238241..240048,2	MCF-7	breast:
44	chr9:331276..333871-chr9:335644..338943,3	MCF-7	breast:
45	chr9:246731..252463-chr9:270869..275661,7	K562	blood:
46	chr9:235818..237375-chr9:247234..248835,2	K562	blood:
47	chr1:27191066..27191830-chr9:408050..409042,2	NB4	blood:
48	chr9:581769..582694-chr9:763829..764743,4	MCF-7	breast:
49	chr9:257830..262248-chr9:271354..273884,5	K562	blood:
50	chr9:462619..465055-chr9:466811..469681,2	K562	blood:

(count:74 , 50 per page) page: 1 2

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C9orf66-2	chr9:454585-454606	ENSG00000227155.3
2	lnc-C9orf66-2	chr9:469722-469836	ENSG00000227155.3
3	lnc-DOCK8-5	chr9:470592-470677	NONHSAT129926
4	lnc-C9orf66-2	chr9:456521-456703	ENSG00000227155.3
5	lnc-C9orf66-2	chr9:459716-459815	ENSG00000227155.3
6	lnc-C9orf66-2	chr9:456915-457047	ENSG00000227155.3
7	lnc-C9orf66-2	chr9:459716-459866	ENSG00000227155.3
8	lnc-C9orf66-1	chr9:272905-273002	ENSG00000235880.1
9	lnc-C9orf66-2	chr9:492084-492112	ENSG00000227155.3
10	lnc-C9orf66-2	chr9:456201-456703	ENSG00000227155.3
11	lnc-DOCK8-5	chr9:471449-471586	NONHSAT129926
12	lnc-C9orf66-2	chr9:459716-460227	ENSG00000227155.3
13	lnc-C9orf66-2	chr9:469722-469802	ENSG00000227155.3
14	lnc-DOCK8-2	chr9:547038-547341	NONHSAT129931
15	lnc-DOCK8-2	chr9:547317-547341	ENSG00000226403.1
16	lnc-DOCK8-5	chr9:484282-484491	NONHSAT129926
17	lnc-C9orf66-7	chr9:503057-504746	NONHSAT129929
18	lnc-C9orf66-2	chr9:454304-454606	ENSG00000227155.1
19	lnc-C9orf66-2	chr9:456201-456703	ENSG00000227155.3
20	lnc-C9orf66-2	chr9:454304-454606	ENSG00000227155.3
21	lnc-C9orf66-2	chr9:465962-466069	ENSG00000227155.3
22	lnc-C9orf66-2	chr9:465962-466065	ENSG00000227155.3
23	lnc-C9orf66-2	chr9:456201-456703	ENSG00000227155.3
24	lnc-C9orf66-2	chr9:488957-489066	ENSG00000227155.3
25	lnc-C9orf66-2	chr9:456518-456703	ENSG00000227155.3
26	lnc-C9orf66-2	chr9:454432-454606	ENSG00000227155.3
27	lnc-C9orf66-2	chr9:470765-470816	ENSG00000227155.3
28	lnc-C9orf66-2	chr9:466688-466866	ENSG00000227155.3
29	lnc-C9orf66-2	chr9:456915-457047	ENSG00000227155.3
30	lnc-C9orf66-2	chr9:456201-456358	ENSG00000227155.1
31	lnc-DOCK8-1	chr9:495238-495610	ENSG00000228115.1
32	lnc-DOCK8-5	chr9:471467-471586	NONHSAT129927
33	lnc-C9orf66-2	chr9:457004-457047	ENSG00000227155.3
34	lnc-C9orf66-2	chr9:456201-456703	ENSG00000227155.3
35	lnc-C9orf66-2	chr9:459716-460507	ENSG00000227155.3
36	lnc-C9orf66-2	chr9:458370-458423	ENSG00000227155.3
37	lnc-C9orf66-2	chr9:456530-456703	ENSG00000227155.3
38	lnc-C9orf66-2	chr9:465962-466069	ENSG00000227155.3
39	lnc-C9orf66-2	chr9:466900-467336	ENSG00000227155.3
40	lnc-C9orf66-8	chr9:507258-507553	NONHSAT129930
41	lnc-C9orf66-2	chr9:459716-459866	ENSG00000227155.3
42	lnc-DOCK8-5	chr9:473194-473273	NONHSAT129927
43	lnc-C9orf66-2	chr9:458117-458281	ENSG00000227155.3
44	lnc-DOCK8-2	chr9:549107-549525	NONHSAT129931
45	lnc-DOCK8-2	chr9:549190-549531	ENSG00000226403.1
46	lnc-C9orf66-2	chr9:456201-456703	ENSG00000227155.3
47	lnc-C9orf66-2	chr9:466688-467390	ENSG00000227155.3
48	lnc-C9orf66-2	chr9:465962-466069	ENSG00000227155.3
49	lnc-DOCK8-2	chr9:549107-549531	ENSG00000226403.1
50	lnc-C9orf66-2	chr9:465962-466069	ENSG00000227155.3

No data

Variant related genes	Relation type
ENSG00000226403	TF binding region
DOCK8	TF binding region
RNU6-1327P	TF binding region
RN7SL412P	TF binding region
ENSG00000235880	TF binding region
ENSG00000228115	TF binding region
ENSG00000227155	TF binding region
KANK1	TF binding region
ENSG00000235330	TF binding region
ENSG00000226403	CpG island
DOCK8	CpG island
RNU6-1327P	CpG island
RN7SL412P	CpG island
ENSG00000235880	CpG island
ENSG00000228115	CpG island
ENSG00000227155	CpG island
KANK1	CpG island
ENSG00000235330	CpG island
ENSG00000169641	chromatin interactions
ENSG00000228115	chromatin interactions
ENSG00000065978	chromatin interactions
ENSG00000183784	chromatin interactions
ENSG00000107104	chromatin interactions
ENSG00000264545	chromatin interactions
ENSG00000235330	chromatin interactions
ENSG00000226403	chromatin interactions
ENSG00000227155	chromatin interactions
ENSG00000074603	chromatin interactions
ENSG00000235880	chromatin interactions
ENSG00000099810	chromatin interactions
ENSG00000107099	chromatin interactions
ENSG00000168209	chromatin interactions

Extended variants
information (count: 24147 )
Associated
traits (count: 125 )

Variant overlapped rSNPs/rCNVs (count:24147 , 50 per page) page: 1 2 3 4 5 6 7 ... 483

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs534352515	chr9:222291-222292	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs187633223	chr9:222295-222296	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs139301712	chr9:222302-222303	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs553340753	chr9:222358-222359	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs77585619	chr9:222380-222381	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs535690996	chr9:222402-222403	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs556870112	chr9:222417-222418	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs113035631	chr9:222437-222438	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs367564766	chr9:222448-222449	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs631722	chr9:222459-222460	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
11	rs537607998	chr9:222486-222487	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs572521471	chr9:222493-222494	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs372540770	chr9:222502-222503	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs183055178	chr9:222521-222522	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs560021259	chr9:222541-222542	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs530324445	chr9:222588-222589	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs531517838	chr9:222638-222639	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs150021664	chr9:222648-222649	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs112756280	chr9:222664-222665	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs187428952	chr9:222696-222697	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs77419002	chr9:222755-222756	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs191843682	chr9:222764-222765	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs543107608	chr9:222808-222809	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs528525365	chr9:222828-222829	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs55748407	chr9:222862-222863	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs546677233	chr9:222905-222906	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs556738819	chr9:222918-222919	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs573780458	chr9:222931-222932	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs568386006	chr9:222957-222958	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs183404921	chr9:222974-222975	Weak transcription Active TSS Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs557174419	chr9:223015-223016	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs568979180	chr9:223060-223061	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs542739472	chr9:223113-223114	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs141299624	chr9:223171-223172	Weak transcription Flanking Active TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs146989810	chr9:223216-223217	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs539886996	chr9:223245-223246	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs35818169	chr9:223264-223265	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs559614221	chr9:223288-223289	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs111929326	chr9:223296-223297	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs147635643	chr9:223331-223332	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs617467	chr9:223332-223333	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs617453	chr9:223339-223340	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
43	rs563977521	chr9:223361-223362	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs542142267	chr9:223382-223383	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs531142547	chr9:223388-223389	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs187895477	chr9:223390-223391	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs564620072	chr9:223454-223455	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs192810418	chr9:223470-223471	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs565275017	chr9:223486-223487	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs547033691	chr9:223489-223490	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:125)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	20164920	CNVD
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Lynch syndrome	18415027	CNVD
Retinoblastoma	21504564	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	22286061	CNVD
Williams-beuren syndrome	18553513	CNVD
Disorders of sex development	21048976	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
prenatal diagnosis	20453657	CNVD
Gastric cancer	16715143	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Autism	22495311	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Schizophrenia	20967226	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Myelodysplastic syndrome	21251322	CNVD
Primary immunodeficiency	22942019	CNVD
Melanoma	20877625	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	21215367	CNVD
Renal cell carcinoma	21215367	CNVD
Williams Syndrome	20824207	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	21364760	CNVD
Bipolar disorder	19114987	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
early-passage human iPS cells	21368824	CNVD
Ependymoma	20639864	CNVD
Schizophrenia	23813976	CNVD
Non-small cell lung cancer	16651412	CNVD
Cancer	21272361	CNVD

Chromatin state (count:7393 , 50 per page) page: 1 2 3 4 5 6 7 ... 148

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:215600-224400	Weak transcription	Spleen	Spleen
2	chr9:216200-225200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
3	chr9:216600-224600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr9:216800-224400	Weak transcription	Placenta	Placenta
5	chr9:217000-225400	Enhancers	Adipose Nuclei	Adipose
6	chr9:217200-224400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr9:217400-222800	Weak transcription	Rectal Mucosa Donor 29	rectum
8	chr9:217400-224400	Weak transcription	Duodenum Mucosa	Duodenum
9	chr9:218000-224400	Weak transcription	Pancreas	Pancrea
10	chr9:218200-222800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
11	chr9:219000-261400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
12	chr9:219600-224600	Enhancers	Primary B cells from peripheral blood	blood
13	chr9:219800-225800	Enhancers	Primary hematopoietic stem cells	blood
14	chr9:220200-222400	Weak transcription	Stomach Mucosa	stomach
15	chr9:220200-222600	Enhancers	Primary B cells from cord blood	blood
16	chr9:220800-223800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
17	chr9:221200-224400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
18	chr9:221400-223800	Weak transcription	Skeletal Muscle Female	skeletal muscle
19	chr9:221400-225600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
20	chr9:221800-222400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr9:221800-222600	Enhancers	Primary T cells fromperipheralblood	blood
22	chr9:221800-222800	Enhancers	Primary T regulatory cells fromperipheralblood	blood
23	chr9:222000-222400	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
24	chr9:222000-223000	Enhancers	HepG2	liver
25	chr9:222000-223200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
26	chr9:222000-223200	Enhancers	Primary T helper cells PMA-I stimulated	--
27	chr9:222000-223400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
28	chr9:222000-223400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
29	chr9:222000-223400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
30	chr9:222000-223400	Enhancers	Gastric	stomach
31	chr9:222000-224800	Enhancers	GM12878-XiMat	blood
32	chr9:222000-225000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
33	chr9:222000-225000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
34	chr9:222000-225200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
35	chr9:222000-225200	Enhancers	Dnd41	blood
36	chr9:222000-226400	Enhancers	K562	blood
37	chr9:222200-222400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
38	chr9:222200-222600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
39	chr9:222200-222600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
40	chr9:222200-222800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
41	chr9:222200-223000	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr9:222200-223200	Weak transcription	Fetal Thymus	thymus
43	chr9:222200-223400	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
44	chr9:222200-224400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
45	chr9:222200-224400	Enhancers	Primary T helper cells fromperipheralblood	blood
46	chr9:222200-224600	Weak transcription	Colonic Mucosa	Colon
47	chr9:222200-225200	Enhancers	HUES64 Cell Line	embryonic stem cell
48	chr9:222400-223000	Enhancers	iPS-15b Cell Line	embryonic stem cell
49	chr9:222400-223000	Enhancers	Primary hematopoietic stem cells short term culture	blood
50	chr9:222400-223000	Enhancers	Stomach Mucosa	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links